Authors: BRUERA E BELZILE M PITUSKIN E FORD I HARSANYL Z DARKE A FREDERICK P

Citation: E. Bruera et al., EFFICACY AND SAFETY OF MORPHINE-SULFATE CONTROLLED-RELEASE SUPPOSITORIES (MS-CRS) ADMINISTERED ONCE-DAILY AND TWICE-DAILY FOR SEVERE CANCERPAIN, Journal of palliative care, 14(3), 1998, pp. 117-117

Authors: BRUERA E BELZILE M PITUSKIN E FAINSINGER R DARKE A HARSANYI Z BABUL N FORD I

Citation: E. Bruera et al., RANDOMIZED, DOUBLE-BLIND, CROSS-OVER TRIAL COMPARING SAFETY AND EFFICACY OF ORAL CONTROLLED-RELEASE OXYCODONE WITH CONTROLLED-RELEASE MORPHINE IN PATIENTS WITH CANCER PAIN, Journal of clinical oncology, 16(10), 1998, pp. 3222-3229

Authors: BRUERA E SEIFERT L WATANABE S BABUL N DARKE A HARSANYI Z SUAREZALMAZOR M

Citation: E. Bruera et al., CHRONIC NAUSEA IN ADVANCED CANCER-PATIENTS - A RETROSPECTIVE ASSESSMENT OF A METOCLOPRAMIDE-BASED ANTIEMETIC REGIMEN, Journal of pain and symptom management, 11(3), 1996, pp. 147-153

Authors: BABUL N DHALIWAL H SLOAN P ARKINSTALL W THIRLWELL M HARSANYI Z DARKE A

Citation: N. Babul et al., ANALGESIC EFFICACY AND SAFETY OF CONTROLLED-RELEASE CODEINE AND PLACEBO IN CANCER PAIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 137-137

Authors: DARKE A MOULIN D PROVENCHER L LABERGE F HARSANYI Z BABUL N

Citation: A. Darke et al., EFFICACY, SAFETY AND PHARMACOKINETICS OF CONTROLLED-RELEASE MORPHINE SUPPOSITORIES AND TABLETS IN CANCER PAIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 165-165

Authors: BABUL N HAGEN N THIRLWELL M DHALIWAL H HARSANYI Z DARKE A

Citation: N. Babul et al., STEADY-STATE DISPOSITION OF HYDROMORPHONE AND HYDROMORPHONE-3-GLUCURONIDE IN CANCER-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 165-165